Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CANB

Can B (CANB) Stock Price, News & Analysis

Can B logo

About Can B Stock (NASDAQ:CANB)

Advanced Chart

Key Stats

Today's Range
$0.0146
$0.0160
50-Day Range
$0.37
$8.24
52-Week Range
$0.27
$1.05
Volume
36,336 shs
Average Volume
189,959 shs
Market Capitalization
$1.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CANB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Can B and its competitors with MarketBeat's FREE daily newsletter.

CANB Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

CANB Stock Analysis - Frequently Asked Questions

Can B (CANB) raised $10 million in an initial public offering on Tuesday, August 9th 2022. The company issued 2,000,000 shares at $5.05 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Can B investors own include Fulcrum Therapeutics (FULC), Actinium Pharmaceuticals (ATNM), Provention Bio (PRVB), VIVUS (VVUS), Chimerix (CMRX), OpGen (OPGN) and Heatwurx (PCSA).

Company Calendar

Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Current Symbol
NASDAQ:CANB
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.74 million
Net Margins
-1,238.33%
Pretax Margin
-1,351.68%

Debt

Sales & Book Value

Annual Sales
$2.16 million
Price / Cash Flow
N/A
Book Value
($0.28) per share
Price / Book
-0.05

Miscellaneous

Free Float
74,137,000
Market Cap
$1.22 million
Optionable
Not Optionable
Beta
1.46
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:CANB) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners